adaPT insight (12C), v1.3.2, PAT.109 (US), Treatment room 4: I2C is used with a charged particle or photon radiation therapy system for localization of the patient position with respect to the therapy equipment and to provide correction feedback to the radiation therapy device.
Published December 31, 2014 · Recall initiated: November 7, 2014
Summary
FDA records medical device Class II recall Z-0836-2015, published December 31, 2014 and initiated November 7, 2014. Recalling firm: Ion Beam Applications S.A.; Status: Terminated; Reported quantity: 1; Lot: PAT.109 (US), Treatment room 4. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Two issues were identified: 1. In the release of adaPT insight v1.3.2., the kV/kV Single Source acquisition workflow was linked to a wrong geometrical calibration file, resulting in an alignment offset for this specific mode of acquisition. 2. A gantry collision incident required the IBA service team to verify the gantry alignment and protons I x-ray beams colinearity, du
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Ion Beam Applications S.A.
- Distributor
- US Distribution in PA only.
- Lot
- PAT.109 (US), Treatment room 4
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- Belgium
Related recalls
- FDAIBA Proton Therapy System - PROTEUS 235 ProteusPLUS and ProteusONE Software versions: PTS-8 versions, PTS-10September 18, 2024
- FDAIBA Proton Therapy System - PROTEUS 235- Designed to produce and deliver a proton beam for the treatment ofAugust 28, 2024
- FDAIBA Proton Therapy System - PROTEUS 235 - Designed to produce and deliver a proton beam for the treatment ofJune 12, 2024
- FDAIBA Proton Therapy System - PROTEUS 235, PTS-10 versions, PTS-11 versions, and PTS-12 versions.May 1, 2024
- FDAFluorescence Imaging Procedure Kit, designed for use with Firefly Fluorescence Imaging for the da Vinci XiDecember 31, 2014
- FDADPM 6 Patient Monitor and DPM 7 Patient Monitor. The product affected is the Mindray IBP module, P/N isDecember 31, 2014
Questions about this recall
Was adaPT insight (12C), v1.3.2, PAT.109 (US), Treatment room 4: I2C is used with a charged particle or photon radiation therapy system for localization of the patient position with respect to the therapy equipment and to provide correction feedback to the radiation therapy device. recalled?
Yes. FDA published recall Z-0836-2015 on December 31, 2014. Reported hazard: Two issues were identified: 1. In the release of adaPT insight v1.3.2., the kV/kV Single Source acquisition workflow was linked to a wrong geometrical calibration file, resulting in an alignment offset for this specific mode of acquisition. 2. A gantry collision incident required the IBA service team to verify the gantry alignment and protons I x-ray beams colinearity, du
What should I do if I have this product?
Voluntary: Firm initiated · Letter